Amphastar P Net Income
| AMPH Stock | USD 20.23 6.26 23.63% |
As of the 28th of February, Amphastar shows the Risk Adjusted Performance of (0.05), mean deviation of 2.13, and Standard Deviation of 3.73. Amphastar P technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Amphastar's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Amphastar's valuation are provided below:Gross Profit 356.1 M | Profit Margin | Market Capitalization 1.2 B | Enterprise Value Revenue 2.2091 | Revenue |
Amphastar | Build AI portfolio with Amphastar Stock |
Is there potential for Pharmaceuticals market expansion? Will Amphastar introduce new products? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.31) | Earnings Share 2.26 | Revenue Per Share 15.401 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0547 |
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Amphastar's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amphastar represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Amphastar's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Amphastar 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amphastar's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amphastar.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in Amphastar on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Amphastar P or generate 0.0% return on investment in Amphastar over 90 days. Amphastar is related to or competes with Cencora, Regeneron Pharmaceuticals, IDEXX Laboratories, Haleon Plc, Cigna Corp, Elevance Health, and Becton Dickinson. Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and pr... More
Amphastar Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amphastar's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amphastar P upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 12.32 | |||
| Value At Risk | (3.98) | |||
| Potential Upside | 3.67 |
Amphastar Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amphastar's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amphastar's standard deviation. In reality, there are many statistical measures that can use Amphastar historical prices to predict the future Amphastar's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.16) |
Amphastar February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 2.13 | |||
| Coefficient Of Variation | (1,228) | |||
| Standard Deviation | 3.73 | |||
| Variance | 13.91 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 12.32 | |||
| Value At Risk | (3.98) | |||
| Potential Upside | 3.67 | |||
| Skewness | (3.78) | |||
| Kurtosis | 23.25 |
Amphastar P Backtested Returns
Amphastar P secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11 % return per unit of risk over the last 3 months. Amphastar P exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amphastar's Mean Deviation of 2.13, risk adjusted performance of (0.05), and Standard Deviation of 3.73 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.99, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Amphastar will likely underperform. At this point, Amphastar P has a negative expected return of -0.42%. Please make sure to confirm Amphastar's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Amphastar P performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.03 |
Virtually no predictability
Amphastar P has virtually no predictability. Overlapping area represents the amount of predictability between Amphastar time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amphastar P price movement. The serial correlation of 0.03 indicates that only 3.0% of current Amphastar price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.03 | |
| Spearman Rank Test | 0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 2.81 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Amphastar P reported net income of 159.52 M. This is 53.26% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 72.06% higher than that of the company.
Amphastar Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amphastar's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amphastar could also be used in its relative valuation, which is a method of valuing Amphastar by comparing valuation metrics of similar companies.Amphastar is currently under evaluation in net income category among its peers.
Amphastar ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amphastar's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amphastar's managers, analysts, and investors.Environmental | Governance | Social |
Amphastar Institutional Holders
Institutional Holdings refers to the ownership stake in Amphastar that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Amphastar's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amphastar's value.| Shares | Millennium Management Llc | 2025-06-30 | 619 K | Renaissance Technologies Corp | 2025-06-30 | 576.5 K | Qube Research & Technologies | 2025-06-30 | 469.5 K | Northern Trust Corp | 2025-06-30 | 421.1 K | Amvescap Plc. | 2025-06-30 | 387 K | Hotchkis & Wiley Capital Management Llc | 2025-06-30 | 365.9 K | Systematic Financial Management Lp | 2025-06-30 | 359.3 K | Goldman Sachs Group Inc | 2025-06-30 | 356.2 K | Charles Schwab Investment Management Inc | 2025-06-30 | 346.8 K | Blackrock Inc | 2025-06-30 | 5.7 M | Vanguard Group Inc | 2025-06-30 | 2.7 M |
Amphastar Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0547 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.6 B | ||||
| Shares Outstanding | 45.95 M | ||||
| Shares Owned By Insiders | 24.49 % | ||||
| Shares Owned By Institutions | 75.56 % | ||||
| Number Of Shares Shorted | 3.72 M | ||||
| Price To Earning | 972.67 X | ||||
| Price To Book | 1.57 X | ||||
| Price To Sales | 1.71 X | ||||
| Revenue | 719.89 M | ||||
| Gross Profit | 356.06 M | ||||
| EBITDA | 149.1 M | ||||
| Net Income | 159.52 M | ||||
| Cash And Equivalents | 183.39 M | ||||
| Cash Per Share | 3.74 X | ||||
| Total Debt | 47.25 M | ||||
| Debt To Equity | 0.21 % | ||||
| Current Ratio | 3.64 X | ||||
| Book Value Per Share | 17.28 X | ||||
| Cash Flow From Operations | 213.39 M | ||||
| Short Ratio | 11.61 X | ||||
| Earnings Per Share | 2.26 X | ||||
| Price To Earnings To Growth | 2.77 X | ||||
| Target Price | 31.29 | ||||
| Number Of Employees | 2.03 K | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 1.23 B | ||||
| Total Asset | 1.63 B | ||||
| Retained Earnings | 666.88 M | ||||
| Working Capital | 360.31 M | ||||
| Current Asset | 175.93 M | ||||
| Current Liabilities | 59.95 M | ||||
| Net Asset | 1.63 B |
About Amphastar Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amphastar P's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amphastar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amphastar P based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is there potential for Pharmaceuticals market expansion? Will Amphastar introduce new products? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.31) | Earnings Share 2.26 | Revenue Per Share 15.401 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0547 |
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Amphastar's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amphastar represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Amphastar's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.